- Home
- TNK vs SPRY Comparison
TNK vs SPRY Comparison
Compare TNK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- SPRY
- Stock Information
- Founded
- TNK 2007
- SPRY 2015
- Country
- TNK Bermuda
- SPRY United States
- Employees
- TNK N/A
- SPRY N/A
- Industry
- TNK Marine Transportation
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- TNK Consumer Discretionary
- SPRY Health Care
- Exchange
- TNK Nasdaq
- SPRY Nasdaq
- Market Cap
- TNK 1.3B
- SPRY 1.4B
- IPO Year
- TNK 2007
- SPRY N/A
- Fundamental
- Price
- TNK $37.52
- SPRY $11.18
- Analyst Decision
- TNK Buy
- SPRY Strong Buy
- Analyst Count
- TNK 3
- SPRY 4
- Target Price
- TNK $63.67
- SPRY $24.00
- AVG Volume (30 Days)
- TNK 387.0K
- SPRY 1.1M
- Earning Date
- TNK 10-30-2024
- SPRY 11-13-2024
- Dividend Yield
- TNK 2.67%
- SPRY N/A
- EPS Growth
- TNK N/A
- SPRY N/A
- EPS
- TNK 12.18
- SPRY N/A
- Revenue
- TNK $1,191,502,000.00
- SPRY $2,568,000.00
- Revenue This Year
- TNK N/A
- SPRY $95,526.66
- Revenue Next Year
- TNK N/A
- SPRY $275.98
- P/E Ratio
- TNK $3.08
- SPRY N/A
- Revenue Growth
- TNK N/A
- SPRY 8460.00
- 52 Week Low
- TNK $36.04
- SPRY $5.10
- 52 Week High
- TNK $74.20
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- TNK 29.52
- SPRY 32.88
- Support Level
- TNK $36.04
- SPRY $10.63
- Resistance Level
- TNK $39.03
- SPRY $14.50
- Average True Range (ATR)
- TNK 1.37
- SPRY 0.82
- MACD
- TNK 0.19
- SPRY -0.20
- Stochastic Oscillator
- TNK 25.78
- SPRY 14.26
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: tanker and ship-to-ship transfer. The vast majority of its revenue comes from the tanker segment, which consists of crude oil and product tankers for different contracts.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.